When is the optimal time to measure MRD in myeloma patients? - 101793

Spotlight
Video

When is the optimal time to measure MRD in myeloma patients?

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: Very soon, minimal residual disease (MRD) testing will become a routine part of clinical practice. Therefore, it is important that clinicians understand when and how to use the tests for the optimal management of multiple myeloma (MM) patients. In this interview, Ola Landgren, MD, PhD, from Memorial Sloan Kettering Cancer Center, NY, describes when you can use MRD testing throughout the treatment journey in MM, in order to support clinical decision making and monitoring of response. This video was recorded during the 23rd congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden.
Shared By : VJHemOnc
Posted on : 07/24/18
Added : 10 months ago
Category : General